News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 449
- Sources here
- 21
- Companies here
- 12
Active search
449 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts
AtriCure, Inc. (NASDAQ:ATRC) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $48.50. The company recently reported strong quarterly results, exceeding EPS and revenue estimates, and provided positive fiscal year 2026 guidance. While institutional ownership is high …
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It
Key Points Karen Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on August 5. The sale resulted in a 14% reduction in the director's total direct equity holdings in the company. All transacted shares were held directly; the director …
ICU Medical Inc (ICUI) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Raised ...
This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ICU Medical Inc (NASDAQ:ICUI) delivered strong Q2 2026 results with total company organic revenue growth …
Atlanticus Holdings Corp Q2 2026: Revenue $744.3M, EPS $2.5— 10-Q Summary
Atlanticus Holdings Corp (ATLC) reported significantly higher revenue and earnings in Q2 2026 compared to the previous year, driven by the expansion of private-label and general-purpose credit receivables and the acquisition of Mercury. Revenue reached $744.3M and diluted EPS was $2.50. The company also …
ICU Medical Q2 2026 Earnings: Organic Growth Supports Higher Guidance
ICU Medical (Nasdaq: ICUI) reported Q2 2026 revenue of $551.7 million, a 1% increase year-over-year, with organic revenue up 6% excluding divestitures and currency effects. The company saw strong performance in Infusion Systems and Consumables, while Vital Care continued to decline. Consequently, ICU Medical …
Cricut Inc (CRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates
Cricut Inc (CRCT) currently has an earnings forecast score of 4.00, placing it 10th in the Integrated Hardware & Software industry, with an average price target of $3.75 from three analysts who generally recommend a "Sell" trend. The company's expected revenue for the next …
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
ICU Medical, Inc. announced its financial results for the second quarter of 2026, reporting GAAP revenue growth of 1% year-over-year, and a non-GAAP organic revenue increase of 6% excluding the impact of a divestiture and foreign currency. The company also updated its fiscal year …
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
ICU Medical (ICUI) reported its Q2 2026 earnings, with revenues of $547.88 million, an increase of 0.8% year-over-year, and EPS of $2.37, up from $2.10 in the prior year. Both revenue and EPS surpassed Zacks Consensus Estimates by 2.33% and 24.08% respectively. Key metrics …
Atlanticus Holdings Corporation (ATLC) Q2 Earnings Meet Estimates
Atlanticus Holdings Corporation (ATLC) came out with quarterly earnings of $2.5 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.51 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was …
Earnings call transcript: Atlanticus posts record Q2 2026 profit as EPS tops forecasts
Atlanticus Holdings reported record second-quarter 2026 profits, with diluted earnings per share of $2.50 exceeding forecasts of $2.41, driven by the Mercury acquisition and growth in legacy receivables. The company saw net income climb 67% year-over-year to $47.4 million and revenue increase 89% to …
Atlanticus Q2 2026 slides: revenue surges 89% on Mercury deal
Atlanticus Holdings Corporation (NASDAQ:ATLC) announced strong Q2 2026 financial results, with revenue surging 89% to $744.3 million, largely driven by the Mercury acquisition. The company reported diluted EPS of $2.50, exceeding analyst expectations, and managed receivables grew to $6.9 billion. Atlanticus highlighted its diversified …
Earnings Flash (ICUI) ICU Medical, Inc. Reports Q2 Revenue $551.7M, vs. FactSet Est of $533.4M
ICU Medical, Inc. (ICUI) announced Q2 2026 revenue of $551.7 million, surpassing the FactSet estimate of $533.4 million. The company also reported Q2 adjusted EPS of $2.37 per share, exceeding the FactSet estimate of $1.91, and has lifted its 2026 guidance. This financial performance …
Atlanticus Holdings (NASDAQ:ATLC) Surprises With Strong Q2 CY2026
Atlanticus Holdings (NASDAQ:ATLC) reported robust Q2 CY2026 results, exceeding market expectations with a 119% year-on-year revenue increase to $744.3 million and GAAP EPS of $2.50, beating analyst estimates by 2.8%. The company highlighted its 30-year history of empowering financial outcomes for millions of consumers …
Cricut, Inc. (CRCT) CEO sells 180,000 shares under Rule 10b5-1 plan
Cricut, Inc. CEO Ashish Arora sold a total of 180,000 shares of Class A Common Stock between August 3 and August 5, 2026. These sales were conducted under a Rule 10b5-1 trading plan established on August 20, 2025, with weighted average prices ranging from …
Cricut CEO Ashish Arora sells USD 1.1 million of Class A common shares
Cricut CEO Ashish Arora sold 179,000 Class A common shares between August 3-5, totaling approximately $1.1 million. The sales prices ranged from $4.77 to $6.26 per share, and following these transactions, Arora now holds 4,207,105 shares in the company. This news brief was generated …
Cricut CEO Ashish Arora sells $938k in shares
Cricut CEO Ashish Arora recently sold 180,000 shares of Class A Common Stock worth approximately $938,672, executed under a Rule 10b5-1 trading plan. These sales occurred over three days in early August 2026, coinciding with a significant rally in CRCT shares. Despite the insider …
SeaStar Medical sets Aug. 12 webcast on results and progress
SeaStar Medical (Nasdaq: ICU) announced it will report its second-quarter 2026 financial results and host a webcast on August 12, 2026, after market close. The webcast and conference call will discuss financial results and business progress, with a replay available for those who cannot …
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
SeaStar Medical Holding Corporation (Nasdaq: ICU) announced it will report its second-quarter financial results on Wednesday, August 12, 2026, after market close. The company will also host a webcast and conference call at 4:30 p.m. ET to discuss its financial performance and business progress. …
Exicure to settle $1M clinical milestone with GPCR Therapeutics via stock issuance in August 2026
Exicure, Inc. will settle a $1 million clinical milestone payment to GPCR Therapeutics by issuing 172,058 shares of common stock, valued at $5.81 each, in August 2026. This payment follows the completion of a Phase 2 trial for Burixafor and the submission of its …
Form 4 Cricut Inc For: 6 August By Investing.com
This article from Investing.com reports on a Form 4 filing for Cricut Inc (CRCT) dated August 6. Form 4s are SEC filings that disclose changes in ownership of company stock by insiders. The article indicates a slight positive movement in Cricut Inc's stock at …
W. R. Berkley (ANSC) discloses 3.27M-share, 9.9% holding in SPAC
W. R. Berkley Corporation, through its subsidiary Berkley Insurance Company, has disclosed a 9.9% beneficial ownership in Agriculture & Natural Solutions Acquisition Corporation (ANSC), a SPAC. This holding amounts to 3,265,181 Class A ordinary shares as of June 30, 2026. The filing indicates shared …
ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026
ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026 Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 1.5% year on year to $551.7 million. Its non-GAAP profit of $2.37 per share was 23.8% above analysts' …